MktsMarkets

Krystal Biotech, Inc.
NASDAQ: KRYSKey statistics
KRYS News
Stories mentioning KRYS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 116,357 | 107,105 | 97,800 | 96,042 | 88,183 | 91,140 | 83,841 | 70,284 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 15,331 | 14,794 | 14,585 | 14,410 | 14,256 | 13,528 | 13,512 | 15,583 |
| Sales General & Admin | 41,014 | 41,356 | 37,578 | 35,160 | 32,647 | 31,269 | 28,673 | 27,626 |
| Total Operating Expenses | 62,668 | 62,743 | 56,426 | 56,735 | 51,931 | 49,746 | 61,369 | 61,718 |
| Operating Income (Loss) | 53,689 | 44,362 | 41,374 | 39,307 | 36,252 | 41,394 | 22,472 | 8,566 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 61,442 | 51,132 | 47,967 | 46,775 | 43,597 | 48,610 | 29,769 | 16,045 |
| Tax Provision | 5,510 | (268.00) | (31,398) | 8,442 | 7,864 | 3,131 | 2,589 | 477.00 |
| Net Income (Loss) | 55,932 | 51,400 | 79,365 | 38,333 | 35,733 | 45,479 | 27,180 | 15,568 |
| Earnings Per Share (Basic) | 1.91 | 1.78 | 2.74 | 1.33 | 1.24 | 1.59 | 0.95 | 0.54 |
| Earnings Per Share (Diluted) | 1.83 | 1.72 | 2.66 | 1.29 | 1.20 | 1.53 | 0.91 | 0.53 |
| Weighted Average Shares Outstanding (Basic) | 29,288 | 28,944 | 28,953 | 28,910 | 28,815 | 28,592 | 28,716 | 28,598 |
| Weighted Average Shares Outstanding (Diluted) | 30,507 | 29,951 | 29,833 | 29,749 | 29,871 | 29,740 | 29,902 | 29,637 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About KRYS
Krystal Biotech, Inc. (NASDAQ: KRYS) is a stock listed on the Nasdaq Stock Market under the ticker symbol KRYS. It last traded at $300.88 (Nov 6, 2026, 4:00 PM ET), up 0.2% on the day. That gives Krystal Biotech a market capitalisation of $8.9B and a price-to-earnings ratio of 39.6.
Over the past 52 weeks KRYS has traded between $192.52 and $382.54.
Revenue for the quarter ended Mar 31, 2026 was $116.4M; net income $55.9M. Revenue was up 31.9% from $88.2M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $116.4M | $55.9M | 48.1% |
| Dec 31, 2025 | $107.1M | $51.4M | 48.0% |
| Sep 30, 2025 | $97.8M | $79.4M | 81.2% |
| Jun 30, 2025 | $96.0M | $38.3M | 39.9% |
From Krystal Biotech’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…